Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the field of hematological malignancies. Novel treatment modalities such as targeted drugs, immunotherapies, and therapy are altering the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering hope for more effective treatment option